Rates of Adverse Events With Hydrogel and Silicone Hydrogel Daily Disposable Lenses in a Large Postmarket Surveillance Registry: The TEMPO Registry [Clinical Trials]

Conclusions.
The CIE rates of 0.4% and 0% with these DD lenses are significantly lower than rates reported with reusable SCLs (3%–4%/y), indicating improved safety outcomes with these DD lenses. Compared to unaffected wearers, SiHyDD lens wearers with AEs requiring clinical visits were significantly older. (ClinicalTrials.gov number, NCT01467557.)

Source: Investigative Ophthalmology - January 29, 2015 Category: Opthalmology Authors: Chalmers, R. L., Hickson-Curran, S. B., Keay, L., Gleason, W. J., Albright, R. Tags: Clinical Trials Source Type: research